$132 Million is the total value of Altium Capital Management LP's 68 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 87.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ADMA | Sell | ADMA BIOLOGICS INC | $8,782,200 | -7.6% | 2,380,000 | -17.1% | 6.65% | +26.1% |
| REPL | Sell | REPLIMUNE GROUP INC | $3,018,600 | +15.5% | 130,000 | -12.2% | 2.28% | +57.5% |
| VERA | Sell | VERA THERAPEUTICS INCcl a | $1,926,000 | -13.2% | 120,000 | -58.0% | 1.46% | +18.3% |
| Sell | MERSANA THERAPEUTICS INCcall | $658,329 | -78.6% | 200,100 | -73.3% | 0.50% | -70.9% | |
| Sell | JEFFS BRANDS LTD*w exp 08/26/202 | $55,721 | -47.5% | 480,770 | -51.0% | 0.04% | -28.8% | |
| ZEVWS | Sell | LIGHTNING EMOTORS INC*w exp 05/18/202 | $991 | -94.0% | 32,608 | -95.0% | 0.00% | -88.9% |
| Exit | GSR II METEORA ACQUISITN COR*w exp 02/24/202 | $0 | – | -50,000 | -100.0% | -0.00% | – | |
| EUCRW | Exit | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $0 | – | -133,333 | -100.0% | -0.00% | – |
| Exit | INNOVATIVE EYEWEAR INC*w exp 08/16/202 | $0 | – | -122,400 | -100.0% | -0.02% | – | |
| Exit | REVELATION BIOSCIENCES INC | $0 | – | -37,198 | -100.0% | -0.03% | – | |
| Exit | PANBELA THERAPEUTICS INC | $0 | – | -335,324 | -100.0% | -0.08% | – | |
| CSSE | Exit | CHICKEN SOUP FOR THE SOUL ENcl a | $0 | – | -212,164 | -100.0% | -0.24% | – |
| VRNA | Exit | VERONA PHARMA PLCsponsored ads | $0 | – | -25,000 | -100.0% | -0.28% | – |
| Exit | GSR II METEORA ACQUISITN COR | $0 | – | -50,000 | -100.0% | -0.29% | – | |
| NVTA | Exit | INVITAE CORP | $0 | – | -409,200 | -100.0% | -0.31% | – |
| Exit | COLISEUM ACQUISITION CORP | $0 | – | -85,000 | -100.0% | -0.48% | – | |
| Exit | THESEUS PHARMACEUTICALS INC | $0 | – | -112,614 | -100.0% | -0.56% | – | |
| Exit | AULT DISRUPTIVE TECHS CORP | $0 | – | -150,000 | -100.0% | -0.87% | – | |
| Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -228,714 | -100.0% | -0.88% | – | |
| PCVX | Exit | VAXCYTE INC | $0 | – | -43,000 | -100.0% | -0.90% | – |
| Exit | GENEDX HOLDINGS CORP | $0 | – | -4,588,000 | -100.0% | -0.93% | – | |
| SILK | Exit | SILK RD MED INC | $0 | – | -45,000 | -100.0% | -0.98% | – |
| Exit | VENTYX BIOSCIENCES INC | $0 | – | -55,000 | -100.0% | -1.02% | – | |
| CVRX | Exit | CVRX INC | $0 | – | -205,000 | -100.0% | -1.06% | – |
| BLRX | Exit | BIOLINERX LTDsponsored ads | $0 | – | -2,279,657 | -100.0% | -1.12% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -178,000 | -100.0% | -1.14% | – |
| Exit | TG VENTURE ACQUISITION CORP | $0 | – | -200,000 | -100.0% | -1.15% | – | |
| ILMN | Exit | ILLUMINA INC | $0 | – | -9,000 | -100.0% | -1.16% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -225,992 | -100.0% | -1.24% | – |
| MDXG | Exit | MIMEDX GROUP INC | $0 | – | -748,000 | -100.0% | -1.42% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -155,000 | -100.0% | -1.43% | – |
| KRMD | Exit | KORU MEDICAL SYSTEMS INC | $0 | – | -685,002 | -100.0% | -1.60% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -12,500 | -100.0% | -1.62% | – |
| VREX | Exit | VAREX IMAGING CORP | $0 | – | -165,000 | -100.0% | -1.67% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -130,000 | -100.0% | -1.76% | – |
| Exit | BIOHAVEN LTD | $0 | – | -260,000 | -100.0% | -1.97% | – | |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -850,000 | -100.0% | -1.98% | – |
| RMD | Exit | RESMED INC | $0 | – | -17,000 | -100.0% | -2.07% | – |
| AKYA | Exit | AKOYA BIOSCIENCES INC | $0 | – | -500,000 | -100.0% | -2.27% | – |
| NEO | Exit | NEOGENOMICS INC | $0 | – | -240,000 | -100.0% | -2.32% | – |
| MYGN | Exit | MYRIAD GENETICS INC | $0 | – | -180,000 | -100.0% | -2.32% | – |
| ATEC | Exit | ALPHATEC HLDGS INC | $0 | – | -270,000 | -100.0% | -2.34% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -16,000 | -100.0% | -2.48% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -91,000 | -100.0% | -2.53% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -500,000 | -100.0% | -2.54% | – |
| Exit | ARCELLX INC | $0 | – | -150,000 | -100.0% | -2.56% | – | |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -1,132,000 | -100.0% | -4.52% | – |
| Exit | NOVOCURE LTDcall | $0 | – | -161,500 | -100.0% | -5.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-08 |
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.